![]() |
市场调查报告书
商品编码
1636784
2030 年合益素产品市场预测:按产品、成分、形式、分销管道、应用、最终用户和地区进行的全球分析Synbiotic Products Market Forecasts to 2030 - Global Analysis By Product, Ingredients, Form, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球合益素产品市场价值为 6.988 亿美元,预计在预测期内将以 9.5% 的复合年增长率增长,到 2030 年将达到 12.046 亿美元。
合益素产品是将益生菌(有益的活微生物)和益生元(难消化的食物成分)结合在一起的营养补充剂和机能性食品,可协同增强肠道健康。乳酸菌和双歧桿菌等益生菌促进肠道菌丛平衡的形成,而源自菊糖和果寡糖等膳食纤维的益生元则为这些微生物提供营养。合益素常见于乳製品、饮料和胶囊中,提供透过优化肠道生态系统来维持整体健康的整体方法。
消费者肠道健康意识不断增强
消费者越来越认识到肠道健康与整体健康之间的联繫,包括改善消化、增强免疫力和增强心理健康。这种意识正在推动对机能性食品和补充剂的需求,这些食品和补充剂结合了益生菌和益生元(称为合益素),以支持平衡的肠道菌群。製造商正在创新饮料和零食等有吸引力的产品形式,以满足不同消费者的喜好。此外,人们对预防性保健的兴趣日益浓厚,鼓励消费者将合益素产品纳入日常生活的一部分。社群媒体、健康宣传活动和营养师的建议进一步放大了这一趋势,推动了全球市场的扩张。
新兴市场缺乏意识
新兴市场的消费者通常对合益素产品可提供的健康益处(例如改善消化和增强免疫力)知之甚少。这种缺乏理解减少了需求。这是因为消费者不太可能投资他们不了解或不理解的产品。此外,製造商的教育宣传活动和行销力度不足也加剧了这个问题。这些市场的医疗保健专业人员也可能不了解合益素的功效,这进一步限制了他们向消费者的推荐。对传统治疗方法相对于现代保健食品的文化偏好是另一个障碍。因此,合益素市场在这些地区难以获得牵引力,削弱了全球扩张潜力。
融入多种食物
融入乳製品、饮料、麵包和谷物等多种食品中,製造商能够满足寻求机能性食品的注重健康的消费者的需求。这种多功能性使合益素产品能够无缝地适应不同的饮食偏好和地区美食,从而增加其吸引力。由于方便,强化食品也被忙碌的消费者广泛采用。此外,食品和生物技术公司之间的合作正在推动合益素配方的创新。因此,合益素市场的需求不断增加,因为它能够将健康益处与易于食用和平易近人的食品形式结合。
可能的副作用和消费者的不信任
腹胀、胀气和过敏等副作用可能会导致使用者不满意。缺乏有关产品安全性和功效的明确资讯进一步加剧了消费者的怀疑。不一致的监管标准和不足的临床证据也削弱了对合益素产品的信任。关于副作用的负面评论和口碑使潜在买家望而却步。此外,由于效果不确定,价格昂贵也阻碍了广泛使用。教育消费者和提高产品透明度对于克服这些挑战至关重要。
COVID-19 的影响
COVID-19 大流行对合益素产品市场产生了重大影响。最初,供应链中断和物流挑战阻碍了生产和分销。然而,消费者对健康和免疫意识的提高推动了对机能性食品(包括合益素产品)的需求。人们越来越多地寻求支持肠道健康和增强免疫功能的产品,从而推动该领域的创新和新产品的推出。随着消费者转向电子商务平台购买保健品,向线上零售的转变进一步推动了市场成长。总体而言,虽然疫情带来了挑战,但它也为合益素产品市场扩大其覆盖范围并顺应健康意识趋势创造了机会。
预计益生菌产业在预测期内将是最大的
由于益生菌对健康的益处有据可查,消费者对肠道健康解决方案的需求不断增长,预计在预测期内益生菌领域将占据最大的市场占有率。作为活的有益细菌,合益素,与益生元结合以增强其功效。由于人们越来越认识到益生菌在改善消化、免疫力和整体健康方面的作用,益生菌在註重健康的消费者中越来越受欢迎。在这个领域,持续的研究和产品创新,包括有针对性的输送系统和菌株特定的好处,正在推动消费者的信心和采用。此外,消化器官系统和生活方式相关疾病的盛行率不断上升,进一步推动了对含有益生菌的合益素产品的需求。
儿童产业预计在预测期内复合年增长率最高。
随着人们越来越认识到肠道健康对整体健康的影响,预计儿童产业在预测期内的复合年增长率最高。父母越来越多地寻求支持孩子消化器官系统健康和免疫力的机能性食品和饮料。合益素产品结合了益生菌和益生元,透过改善营养吸收和强化肠道微生物群来满足这项需求。年轻人胃肠道疾病和过敏症的盛行率日益增加,刺激了对此类客製化治疗的需求。製造商也正在开发有吸引力的口味和儿童友善的形式,例如软糖和粉末,以鼓励消费。这种对儿童的关注符合更广泛的健康趋势,推动了这一领域的市场成长。
由于益生菌和益生元组合的优势,预计亚太地区在预测期内将占据最大的市场占有率。健康意识的增强和胃肠道疾病盛行率的增加正在推动对机能性食品和营养补充剂的需求。中国、日本和印度等国家走在前列,扩大了产品系列以针对不同的年龄层。合益素融入乳製品、饮料、婴儿营养品表现尤为明显。此外,主要企业的配方创新和研发投入的增加也进一步支持了市场发展。
由于消费者对肠道健康的认识不断提高以及益生菌和益生元相结合的好处,预计北美在预测期内将表现出最高的复合年增长率。对机能性食品和营养补充剂的需求不断增长以及对预防保健的关注正在推动市场扩张。该地区强劲的食品和饮料行业以及生物技术的进步进一步推动了产品创新和供应。典型应用包括乳製品、婴儿奶粉和营养补充品。领先的公司正在投资研发和策略伙伴关係,以跟上不断变化的消费者偏好,确保这个注重健康的市场的稳定成长。
According to Stratistics MRC, the Global Synbiotic Products Market is accounted for $698.8 million in 2024 and is expected to reach $1204.6 million by 2030 growing at a CAGR of 9.5% during the forecast period. Synbiotic products are dietary supplements or functional foods that combine probiotics (beneficial live microorganisms) and prebiotics (non-digestible food ingredients) to synergistically enhance gut health. Probiotics, such as Lactobacillus or Bifidobacterium strains, promote a balanced gut microbiota, while prebiotics, often derived from fibers like inulin or fructooligosaccharides, serve as nourishment for these microbes. Synbiotics are commonly found in dairy products, beverages, or capsules, offering a holistic approach to maintaining overall health by optimizing the gut's ecosystem.
Rising consumer awareness about gut health
Consumers are increasingly recognizing the connection between gut health and overall well-being, including improved digestion, enhanced immunity, and better mental health. This awareness has fuelled demand for functional foods and supplements that combine probiotics and prebiotics, known as synbiotics, to support a balanced gut microbiome. Manufacturers are innovating with appealing product formats, such as beverages and snacks, to cater to diverse consumer preferences. Additionally, growing interest in preventive healthcare has encouraged consumers to adopt synbiotic products as part of their daily routines. The trend is further amplified by social media, health campaigns, and endorsements by nutritionists, driving market expansion globally.
Lack of awareness in emerging markets
Consumers in these regions often have limited knowledge about the health benefits of synbiotic products, such as improved digestion and immunity. This lack of understanding reduces demand, as individuals are less likely to invest in products they do not recognize or understand. Additionally, insufficient educational campaigns and marketing efforts by manufacturers exacerbate the problem. Healthcare professionals in these markets may also be unaware of synbiotic benefits, further limiting recommendations to consumers. Cultural preferences for traditional remedies over modern health products create an additional barrier. As a result, the market struggles to gain traction in these regions, stalling its global expansion potential.
Integration into diverse food products
Integration into diverse food products like dairy, beverages, bakery, and cereals, manufacturers cater to health-conscious consumers seeking functional foods. This versatility allows synbiotic products to seamlessly align with varying dietary preferences and regional cuisines, enhancing their appeal. The convenience of fortified food options also encourages wider adoption among busy consumers. Additionally, collaborations between food companies and biotech firms are fostering innovation in synbiotic formulations. As a result, the market experiences increased demand due to its ability to blend health benefits with palatable and familiar food formats.
Potential side effects and consumer mistrust
Adverse reactions such as bloating, gas, or allergies can lead to dissatisfaction among users. Lack of clear information about product safety and efficacy further amplifies consumer skepticism. Inconsistent regulatory standards and insufficient clinical evidence also undermine trust in synbiotic products. Negative reviews and word-of-mouth about side effects deter potential buyers. Additionally, high prices for perceived uncertain benefits discourage widespread adoption. Educating consumers and improving product transparency are essential to overcoming these challenges.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the synbiotic products market. Initially, disruptions in supply chains and logistical challenges hindered production and distribution. However, growing consumer awareness about health and immunity boosted demand for functional foods, including synbiotic products. People increasingly sought products that support gut health and enhance immune function, driving innovation and new product launches in the sector. The shift toward online retail further facilitated market growth, as consumers adapted to e-commerce platforms for purchasing health supplements. Overall, while the pandemic presented challenges, it also created opportunities for the synbiotic products market to expand its reach and align with health-conscious trends.
The probiotics segment is expected to be the largest during the forecast period
The probiotics segment is expected to account for the largest market share during the forecast period, due to its well-documented health benefits and growing consumer demand for gut health solutions. Probiotics, as live beneficial bacteria, form a key component of synbiotic formulations, which combine them with prebiotics to enhance their efficacy. Increasing awareness of probiotics' role in improving digestion, immunity, and overall well-being has fuelled their popularity among health-conscious consumers. The segment benefits from ongoing research and product innovations, such as targeted delivery systems and strain-specific benefits, which boost consumer trust and adoption. Additionally, the rising prevalence of digestive disorders and lifestyle-related ailments further drives demand for probiotics-infused synbiotic products.
The children segment is expected to have the highest CAGR during the forecast period
The children segment is anticipated to witness the highest CAGR during the forecast period, due to the growing awareness of gut health's impact on overall well-being. Parents increasingly seek functional foods and beverages to support their children's digestive health and immunity. Synbiotic products, combining probiotics and prebiotics, cater to these demands by improving nutrient absorption and enhancing gut microbiota. Rising rates of digestive disorders and allergies in youngster's fuel demand for such customised remedies. Manufacturers are also developing appealing flavours and child-friendly formats, like gummies and powders, to encourage consumption. This focus on children aligns with broader health trends, boosting the segment's market growth.
Asia Pacific is expected to hold the largest market share during the forecast period due to the benefits of combining probiotics and prebiotics. Rising health consciousness, coupled with the growing prevalence of gastrointestinal disorders, has boosted demand for functional foods and dietary supplements. Countries like China, Japan, and India are at the forefront, with expanding product portfolios targeting diverse age groups. The integration of synbiotics into dairy products, beverages, and infant nutrition is particularly prominent. Moreover, innovation in formulation and increasing investments in research and development by key players further fuel market expansion.
North America is expected to have the highest CAGR over the forecast period, owing to increased consumer awareness of gut health and the benefits of combining probiotics and prebiotics. Rising demand for functional foods and dietary supplements, coupled with a focus on preventive healthcare, fuels the market's expansion. The region's robust food and beverage industry and advancements in biotechnology further support product innovation and availability. Key applications include dairy products, infant formula, and nutraceuticals. Major players are investing in R&D and strategic partnerships to meet evolving consumer preferences, ensuring steady growth in this health-conscious market.
Key players in the market
Some of the key players profiled in the Synbiotic Products Market include Seed Health, Inc., Sabinsa Corporation, Biomin America Inc., Probiotical S.p.A., Chobani Global Holdings LLC, United Natural Foods, Herbalife Nutrition Ltd., Yakult Honsha Co., Inc., Pfizer Inc., Daflorn Ltd., Danone S.A., HUM Nutrition, Aspera BY NU3X, Synbiotic Health and Chr. Hansen Holding A/S.
In October 2024, Sabinsa Corporation announced a multinational distribution agreement with Postbiotics, Inc. This agreement covers significant markets including the U.S., Canada, the European Union, India, and Japan. The partnership aims to distribute PoZibio, a dietary supplement and functional food ingredient that focuses on health benefits associated with postbiotics.
In September 2024, Seed Health partnered with Target to distribute its products in all Target stores and on Target's website. This partnership marks Seed Health's first collaboration with a major retailer, aiming to broaden access to its microbiome-directed innovations.
In May 2024, Seed Health launched VS-01(TM) Vaginal Synbiotic, the first clinically validated vaginal synbiotic designed to rapidly establish an optimal vaginal microbiome dominated by Lactobacillus crispatus. This product aims to redefine vaginal care by restoring the vagina's protective bacteria.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.